Literature DB >> 22379176

Repeated cross-sectional survey of patient-reported asthma control in Europe in the past 5 years.

P Demoly1, K Annunziata, E Gubba, L Adamek.   

Abstract

Although the main goal of asthma management guidelines is to achieve and maintain clinical control, reported levels of not well-controlled asthma remain high. The aim of this analysis was to compare the levels of asthma control and the associated impact on patients' health status in Europe in 2006, 2008 and 2010. An additional outcome was the comparison of the burden of asthma with diabetes. Data were obtained from the cross-sectional, self-reported, European National Health and Wellness Surveys conducted in France, Germany, Italy, Spain and the UK. Asthma control (Asthma Control Test™; QualityMetric, Inc., Lincoln, RI, USA) and health status (Short Form (SF)-12 health survey and the Work Productivity Loss and Activity Impairment questionnaire) were assessed. In 2010, the proportion of treated asthma patients assessed as having not well-controlled asthma was 53.5%, compared with 56.6% and 55.0% in 2008 and 2006, respectively. A significant reduction in not well-controlled asthma was observed in Germany between 2006 (72.3%) and 2010 (62.5%; p=0.005). Fluctuations in control levels were observed in other countries. For all surveys, having at least well-controlled asthma was associated with a significantly lower number of healthcare contacts in the previous 6 months, better mean±(SD) SF-12 scores for the physical (data for 2010: not well controlled 39.9±11.38, at least well-controlled 48.0±9.89; p<0.001) and mental (data for 2010: not well-controlled 40.6±10.95, at least well-controlled 45.0±10.91; p<0.001) components, and significantly less impact on Work Productivity Loss and Activity Impairment. Asthma and diabetes were associated with a similar overall negative impact on health status. A substantial proportion of asthmatics remain not well-controlled across five European countries, resulting in a significant impact on health resources and patients' health status. The overall burden of asthma appears to be similar to that of diabetes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22379176     DOI: 10.1183/09059180.00008111

Source DB:  PubMed          Journal:  Eur Respir Rev        ISSN: 0905-9180


  62 in total

1.  Management of asthma in Benin: the challenge of loss to follow-up.

Authors:  G Ade; M Gninafon; L Tawo; N Aït-Khaled; D A Enarson; C-Y Chiang
Journal:  Public Health Action       Date:  2013-02-28

2.  An official American Thoracic Society Workshop Report: presentations and discussion of the fifth Jack Pepys Workshop on Asthma in the Workplace. Comparisons between asthma in the workplace and non-work-related asthma.

Authors:  Jean-Luc Malo; Susan M Tarlo; Joaquin Sastre; James Martin; Mohamed F Jeebhay; Nicole Le Moual; Dick Heederik; Thomas Platts-Mills; Paul D Blanc; Olivier Vandenplas; Gianna Moscato; Frédéric de Blay; André Cartier
Journal:  Ann Am Thorac Soc       Date:  2015-07

Review 3.  Nocturia Work Productivity and Activity Impairment Compared with Other Common Chronic Diseases.

Authors:  Paul S J Miller; Harry Hill; Fredrik L Andersson
Journal:  Pharmacoeconomics       Date:  2016-12       Impact factor: 4.981

4.  Depressive symptoms, quality of sleep, and disease control in women with asthma.

Authors:  Francineide Lima Campos; Pedro Felipe Carvalhedo de Bruin; Thisciane Ferreira Pinto; Francisco Girleudo Coutinho da Silva; Eanes Delgado Barros Pereira; Veralice Meireles Sales de Bruin
Journal:  Sleep Breath       Date:  2016-10-29       Impact factor: 2.816

5.  Association Between Insomnia and Asthma Burden in the Severe Asthma Research Program (SARP) III.

Authors:  Faith S Luyster; Patrick J Strollo; Fernando Holguin; Mario Castro; Eleanor M Dunican; John Fahy; Benjamin Gaston; Elliot Israel; Nizar N Jarjour; David T Mauger; Wendy C Moore; Sally E Wenzel
Journal:  Chest       Date:  2016-10-06       Impact factor: 9.410

6.  Cost-utility analysis of an intervention designed to reduce the critical handling error of insufficient inspiratory effort.

Authors:  Rebecca Forster; Aran Ratcliffe; Megan Lewis; Amy Crossley; Julio López Bastida; William C N Dunlop
Journal:  Eur J Health Econ       Date:  2018-05-12

Review 7.  Role of monoclonal antibodies in the treatment of asthma.

Authors:  Paul M O'Byrne
Journal:  Can Respir J       Date:  2013 Jan-Feb       Impact factor: 2.409

8.  Comparison of clinical characteristics and management of asthma by types of health care in South Korea.

Authors:  Eun Yeong Cho; Ki Jong Oh; Chin Kook Rhee; Kwang Ha Yoo; Bo Yeon Kim; Hye Won Bae; Byung-Jae Lee; Dong-Chull Choi; Hyun Lee; Hye Yun Park
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

9.  Nationwide use of inhaled corticosteroids by South Korean asthma patients: an examination of the Health Insurance Review and Service database.

Authors:  Joon Young Choi; Hyoung Kyu Yoon; Jae Ha Lee; Kwang Ha Yoo; Bo Yeon Kim; Hye Won Bae; Young Kyoon Kim; Chin Kook Rhee
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

10.  In-Patient Pulmonary Rehabilitation to Improve Asthma Control–A Randomized Controlled Study (EPRA, Effectiveness of Pulmonary Rehabilitation for Patients with Asthma).

Authors:  Konrad Schultz; Michael Wittmann; Rupert Wagner; Nicola Lehbert; Larissa Schwarzkopf; Boglárka Szentes; Dennis Nowak; Hermann Faller; Michael Schuler
Journal:  Dtsch Arztebl Int       Date:  2021-01-22       Impact factor: 5.594

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.